37 Views | 13 Downloads
Milkie Vu, Northwestern University, 680 N. Lakeshore Drive, Suite 1400, Chicago, IL 60611. Phone: 312-503-6592; E-mail: milkie.vu@northwestern.edu
M. Vu: Conceptualization, data curation, formal analysis, methodology, writing-original draft, writing-review and editing. K. Boyd: Data curation, writing-review and editing. E.H. De Marchis: Conceptualization, writing-review and editing. B.G. Garnache: Data curation, writing-review and editing. L.M. Gottlieb: Conceptualization, writing-review and editing. C.P. Gross: Conceptualization, resources, funding acquisition, writing-review and editing. N.K. Lee: Data curation, writing-review and editing. S.T. Lindau: Conceptualization, resources, data curation, funding acquisition, writing-review and editing. S. Mun: Resources, data curation, writing-review and editing. V.A. Winslow: Formal analysis, validation, methodology, writing-review and editing. J.A. Makelarski: Conceptualization, resources, formal analysis, methodology, writing-review and editing.
This work was supported by pilot funding from the University of Chicago Comprehensive Cancer Center (P30CA014599) and grants R01MD012630, R01AG064949, and R21CA226726. This content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding for open access publication is supported by the Northwestern University Libraries.
S.T. Lindau is founder and co-owner of NowPow LLC, a company acquired in September 2021 by Unite Us LLC, where S.T. Lindau is a paid advisor and a stockholder. S.T. Lindau is president of MAPSCorps, a 501c3 nonprofit organization, and serves on other nonprofit boards. Neither the University of Chicago nor the University of Chicago Medicine endorses or promotes any NowPow, Unite Us or MAPSCorps product or service. S.T. Lindau holds debt in Glenbervie Health LLC and health care–related investments managed by third parties. S.T. Lindau is a contributor to UpToDate Inc. The University of Chicago receives royalties from UpToDate Inc. C.P. Gross has received research funding from the NCCN Foundation (AstraZeneca; paid through Yale), from Johnson and Johnson to help devise and implement new approaches to sharing clinical trial data (paid through Yale) as well as research funding from Genentech (paid to C.P. Gross). N.K. Lee received funding from the National Ovarian Cancer Coalition (honorarium for consultation on educational content). C.P. Gross reports grants from Johnson and Johnson and NCCN (AstraZeneca), and personal fees from Genentech outside the submitted work. S.T. Lindau reports grants from NIH and other from Unite Us, LLC, UpToDate, INC, and Glenbervie Health, LLC during the conduct of the study. No disclosures were reported by the other authors.